Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 9/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4449569 | 0.88 | AHR (0.58) | AHRCYP3A4ALDH1A1MAPK1HPGD | |
| SCHEMBL2230317 | 0.84 | AHR (0.52) | AHRCYP3A4ALDH1A1MAPK1HPGD | |
| SCHEMBL4453307 | 0.84 | AHR (0.52) | AHRCYP3A4ALDH1A1MAPK1TDP1 | |
| SCHEMBL30301086 | 0.84 | AHR (0.52) | AHRCYP3A4ALDH1A1MAPK1HPGD | |
| SCHEMBL29492227 | 0.84 | AHR (0.52) | AHRCYP3A4ALDH1A1MAPK1TDP1 | |
| Water SCHEMBL11727747 | 0.82 | AHR (0.50) | AHRCYP3A4MAPK1TDP1ALPL | |
| SCHEMBL4459649 | 0.80 | AHR (0.54) | AHRCYP3A4ALDH1A1MAPK1HPGD | |
| SCHEMBL4456805 | 0.79 | CYP3A4 (0.61) | AHRCYP3A4ALDH1A1MAPK1HPGD | |
| SCHEMBL30035000 | 0.79 | CYP3A4 (0.61) | AHRCYP3A4ALDH1A1MAPK1HPGD | |
| SCHEMBL4449764 | 0.78 | AHR (0.54) | AHRCYP3A4ALDH1A1MAPK1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220351865-A1 | METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS | GERO PTE. LTD. (SG) | 2022-11-03 | — | — | US | claimed |
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | claimed |
| CN-116482813-B | Compact micro-platform for optical transceiver assembly | 云晖科技有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-20230330725-A1 | VOLATILIZATION AND OXIDATION OF ORGANIC WASTE | NATIONAL BANK OF CANADA (CA) | 2023-10-19 | — | — | US | disclosed |
| CN-116482813-A | Compact micro-platform for optical transceiver assembly | 东莞云晖光电有限公司 | 2023-07-25 | — | — | CN | disclosed |
| US-20230047816-A1 | PFKFB3 INHIBITORS AND THEIR USES | GERO PTE. LTD. (SG) | 2023-02-16 | — | — | US | disclosed |
| US-20220351865-A1 | METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS | GERO PTE. LTD. (SG) | 2022-11-03 | — | — | US | disclosed |
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | disclosed |
| EP-1616022-A2 | TEST SYSTEM FOR DETECTING CONTAMINANTS | Crown Vision Systems Limited (GB) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004090156-A2 | TEST SYSTEM FOR DETECTING CONTAMINANTS | CROWN VISION SYSTEMS LIMITED (GB) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047816-A1 | PFKFB3 INHIBITORS AND THEIR USES | PFKFB3, PFKFB4, PFKFB1 | AHR 3353/4885CYP3A4 2539/4885ALDH1A1 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.